CERT

Certara Inc

10.19

Oct 21 • 12:01 PM ET +0.40 (4.14%)

Healthcare Health Information Services USA Small NASD

Peers: SDGR VEEV TEM RXRX ICLR ABSI IQV CRL MEDP DNA

| Held by: IJR VTI IWM DFSV VB DFAT VBR VXF IWN SPSM

Index	RUT
Market Cap	1.55B
Enterprise Value	1.67B
Income	-2.92M
Sales	408.45M
Book/sh	6.34
Cash/sh	1.21
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	1576
IPO	Dec 11, 2020

P/E	-
Forward P/E	25.62
PEG	102.47
P/S	3.81
P/B	1.61
P/C	8.44
P/FCF	19.34
EV/EBITDA	18.16
EV/Sales	4.09
Quick Ratio	2.55
Current Ratio	2.55
Debt/Eq	0.31
LT Debt/Eq	0.31
Option/Short	Yes / Yes

EPS (ttm)	-0.02
EPS next Y	0.40
EPS next Q	0.09
EPS this Y	-22.70%
EPS next Y	16.96%
EPS next 5Y	0.25%
EPS past 3/5Y	- 50.19%
Sales past 3/5Y	7.66% 11.45%
EPS Y/Y TTM	-134.07%
Sales Y/Y TTM	0.66%
EPS Q/Q	642.62%
Sales Q/Q	-10.81%
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-10.41% -4.91%

Insider Own	36.33%
Insider Trans	0.00%
Inst Own	77.64%
Inst Trans	2.37%
ROA	-1.31%
ROE	-1.89%
ROIC	-0.23%
Gross Margin	48.49%
Oper. Margin	4.63%
Profit Margin	-0.72%
SMA20	8.98%
SMA50	17.83%
SMA200	41.15%
Trades

Shs Outstand	152.50M
Shs Float	97.12M
Short Float	28.53%
Short Ratio	9.15
Short Interest	27.70M
52W High	12.94 -21.25%
52W Low	4.45 128.99%
Volatility	4.86% 5.18%
ATR (14)	0.47
RSI (14)	64.52
Beta	1.34
Rel Volume	0.34
Avg Volume	3.03M
Volume	438,803

Perf Week	8.87%
Perf Month	15.40%
Perf Quarter	43.32%
Perf Half Y	59.72%
Perf YTD	15.66%
Perf Year	-16.95%
Perf 3Y	-24.57%
Perf 5Y	-73.58%
Perf 10Y	-
Recom	2.38
Target Price	9.17
Prev Close	9.78
Price	10.19
Change %	4.14%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Overweight → Equal Weight	$8
Feb-27-26	Downgrade	Craig Hallum	Buy → Hold	$10
Jan-06-26	Upgrade	Leerink Partners	Market Perform → Outperform	$13
Nov-21-25	Initiated	Rothschild & Co Redburn	Buy	$10
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$9
Sep-29-25	Initiated	Craig Hallum	Buy	$16
Jul-03-25	Resumed	Morgan Stanley	Equal-Weight	$16
May-08-25	Upgrade	Barclays	Equal Weight → Overweight	$14
Feb-27-25	Initiated	TD Cowen	Buy	$16
Sep-27-24	Upgrade	UBS	Neutral → Buy	$16
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$23
Apr-04-24	Initiated	JMP Securities	Mkt Perform
Feb-26-24	Initiated	Leerink Partners	Market Perform	$19
Dec-07-23	Initiated	UBS	Neutral	$17
Dec-05-23	Initiated	KeyBanc Capital Markets	Sector Weight
Aug-22-23	Downgrade	Jefferies	Buy → Hold	$24.50 → $17
Aug-10-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-12-23	Initiated	Stephens	Overweight	$28
Apr-03-23	Downgrade	Barclays	Overweight → Equal Weight	$25
Dec-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$17 → $19

Show Previous Ratings

Oct-08-26 07:58PM	What Could Go Wrong With Recursion Pharmaceuticals Stock? (Trefis) +5.67%
Aug-04-26 08:59PM	Certara, Inc. Q2 2026 Earnings Call Summary (Moby)
07:00AM	Certara Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-23-26 09:05AM	An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers (PR Newswire)
Jul-15-26 04:15PM	Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026 (GlobeNewswire) +5.85%
08:54AM	Loading…
Jul-07-26 08:54AM	Certara teams up with Nvidia to strengthen AI platform with BioNeMo toolkit (CERT) (InvestorsHub)
08:00AM	Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit (GlobeNewswire)
Jul-06-26 08:55AM	As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models (PR Newswire)
08:45AM	The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel (PR Newswire)
Jun-17-26 04:30PM	Certara Announces CFO Transition (GlobeNewswire) -8.13%
Jun-16-26 08:45AM	The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It (PR Newswire) +16.12%
May-18-26 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-26 03:03AM	Certara Inc (CERT) Q1 2026 Earnings Call Highlights: Navigating Modest Growth and Strategic ... (GuruFocus.com)
May-11-26 10:17AM	Certara (CERT) Shares Slide After Weak Full-Year Guidance Overshadows Revenue Beat (InvestorsHub) -18.70%
06:25AM	Certara Reports First Quarter 2026 Financial Results (GlobeNewswire)
08:00AM	Loading…
May-07-26 08:00AM	Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development (Business Wire)
Apr-22-26 07:00AM	Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat (GlobeNewswire)
Apr-09-26 04:15PM	Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 (GlobeNewswire)
Mar-07-26 11:02PM	Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference (MarketBeat)
Mar-03-26 08:00AM	Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib (GlobeNewswire)
Feb-27-26 08:30AM	Certara, Inc. Q4 2025 Earnings Call Summary (Moby)
08:30AM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-26-26 04:08PM	Certara Inc (CERT) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
12:06PM	Certara Q4 Earnings Call Highlights (MarketBeat)
08:15AM	Certara, Inc. (CERT) Q4 Earnings Lag Estimates (Zacks)
06:00AM	Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance (GlobeNewswire)
Feb-10-26 02:56PM	Analyst Sentiment on Certara (CERT) Remains Moderately Bullish Despite Sector Volatility (Insider Monkey)
Jan-29-26 08:30AM	Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025 (GlobeNewswire)
Jan-27-26 07:38AM	Lower-Than-Expected Service Bookings Impacted Certara (CERT) in Q4 (Insider Monkey)
Dec-12-25 10:15AM	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave (PR Newswire)
06:00AM	Loading…
Dec-11-25 06:00AM	Certara Appoints Jon Resnick as Chief Executive Officer (GlobeNewswire) -5.06%
Dec-09-25 03:33PM	Do Options Traders Know Something About CERT Stock We Don't? (Zacks)
Dec-08-25 12:20PM	Earnings Estimates Moving Higher for Certara (CERT): Time to Buy? (Zacks)
09:55AM	Wall Street Analysts Think Certara (CERT) Could Surge 43.28%: Read This Before Placing a Bet (Zacks)
Nov-07-25 12:13AM	Certara Inc (CERT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Booking Challenges (GuruFocus.com) -23.07%
Nov-06-25 06:55PM	Certara, Inc. (CERT) Q3 Earnings Surpass Estimates (Zacks)
04:15PM	Certara Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 10:00AM	Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
08:00AM	Certara Automates Scientific Workflows with Phoenix Cloud (GlobeNewswire)
Oct-31-25 08:00AM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-30-25 04:15PM	Certara Expands Biosimulation Market with AI-Driven QSP Platform (GlobeNewswire)
10:00AM	Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-20-25 08:00AM	Certara Scientists are Among the Topmost Cited Biopharma Researchers (GlobeNewswire)
Oct-10-25 08:00AM	Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 (GlobeNewswire) -8.35%
Oct-02-25 09:13AM	Can Doximity's New AI Suite Drive the Growth It Needs? (Zacks)
Sep-04-25 08:00AM	Certara Launches Pinnacle 21 Enterprise Plus to Deliver Regulatory Submissions Faster (GlobeNewswire)
Sep-02-25 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-07-25 03:28PM	Certara, Inc. (CERT): A Bull Case Theory (Insider Monkey) +18.15%
Aug-06-25 06:00PM	Certara, Inc. (CERT) Q2 Earnings Miss Estimates (Zacks)
04:15PM	Certara Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 02:00AM	Certara Simcyp Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling (GlobeNewswire)
Jul-31-25 04:15PM	Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform (GlobeNewswire)
10:00AM	Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-30-25 10:00AM	Certara, Inc. (CERT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-29-25 08:25AM	Alkermes (ALKS) Tops Q2 Earnings and Revenue Estimates (Zacks)
Jul-18-25 08:38AM	Do Options Traders Know Something About Certara Stock We Don't? (Zacks)
Jul-15-25 01:56PM	Simulations Plus Sees Weaker Demand Persist, Outlook Softens (Benzinga) -6.55%
Jul-11-25 12:10PM	Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-10-25 12:39AM	Morgan Stanley Assumes Coverage of Certara (CERT) Stock (Insider Monkey)
Jul-09-25 04:15PM	Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 (GlobeNewswire)
Jul-08-25 12:05PM	VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait? (Zacks)
08:00AM	Certara Announces Expansion of Clinical Technology Collaboration with Merck (GlobeNewswire)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-20-25 08:25AM	Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS? (Zacks)
May-23-25 09:17AM	AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge (PR Newswire)
May-06-25 08:31AM	Q1 2025 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -11.03%
03:09AM	Certara Inc (CERT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-05-25 07:22PM	Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:45PM	Certara, Inc. (CERT) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:15PM	Certara Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
10:01AM	Sarepta Therapeutics (SRPT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-28-25 10:00AM	Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-21-25 08:00AM	3 Momentum Stocks That Could Soar Post-Market Volatility (MarketBeat)
Apr-16-25 12:10PM	Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-15-25 12:40AM	Why Certara Inc. (CERT) Skyrocketed On Monday? (Insider Monkey)
Apr-14-25 08:15AM	Certara Launches Non-Animal Navigator Solution to Help Drug Developers Reduce Reliance on Animal Testing (GlobeNewswire) +11.54%
08:00AM	Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization (GlobeNewswire)
Apr-12-25 06:45PM	Why Certara Inc. (CERT) Soared Last Week? (Insider Monkey)
02:10AM	Why Certara Inc. (CERT) Surged On Friday? (Insider Monkey)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +22.84%
10:04AM	Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? (Zacks)
Apr-02-25 12:49PM	Checking Back In On Certara: Unattractive Valuation (Seeking Alpha)
Apr-01-25 08:00AM	Certara Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities (GlobeNewswire)
Mar-06-25 07:58PM	Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts (Insider Monkey)
Mar-05-25 04:15PM	Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions (GlobeNewswire)
Feb-27-25 07:59AM	Q4 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:28AM	Certara Inc (CERT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Feb-26-25 06:45PM	Certara, Inc. (CERT) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:15PM	Certara Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
Feb-14-25 01:12PM	Certara, Inc. (CERT): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey)
Jan-29-25 04:15PM	Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-24-25 12:48PM	Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerinks Target Price Boost to $13 (Insider Monkey)
Jan-15-25 07:55AM	Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) +11.36%
Jan-02-25 04:15PM	Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.16%
Dec-06-24 10:02AM	Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q3 (Insider Monkey)
Dec-02-24 04:15PM	Certara Showcases 2024 Research Wins With Over 100 Papers Published (GlobeNewswire)
Nov-13-24 09:29AM	Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 (Insider Monkey)
Nov-07-24 10:38AM	Q3 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
02:27AM	Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pedersen Leif E	Officer	Sep 03 '26	Proposed Sale	8.32	36,066	300,069		Sep 03 11:09 AM
Anhalt Rona	Chief Human Resources Officer	Jun 01 '26	Option Exercise	0.00	7,147	0	19,030	Jun 02 05:15 PM
Corcoran Daniel	SVP and General Counsel	Jun 01 '26	Option Exercise	0.00	22,830	0	39,939	Jun 02 05:14 PM
Collins Cynthia	Director	May 14 '26	Option Exercise	0.00	15,757	0	51,846	May 15 04:31 PM
Reynders John V W	Chief Financial Officer	May 14 '26	Option Exercise	0.00	15,757	0	26,466	May 15 04:29 PM
BROSHY ERAN	Chairman	May 14 '26	Option Exercise	0.00	15,757	0	50,708	May 15 04:28 PM
Bedi Arjun	Director	May 14 '26	Option Exercise	0.00	5,547	0	5,547	May 15 04:28 PM
CASHMAN JAMES E III	Chairman	May 14 '26	Option Exercise	0.00	15,757	0	484,197	May 15 04:27 PM
Killefer Nancy	Director	May 14 '26	Option Exercise	0.00	15,757	0	51,846	May 15 04:26 PM
Crane Rosemary A	Director	May 14 '26	Option Exercise	0.00	15,757	0	45,672	May 15 04:26 PM
WALSH MATTHEW M	Director	May 14 '26	Option Exercise	0.00	15,757	0	213,316	May 15 04:25 PM
Resnick Jon Matthew	Chief Executive Officer	May 11 '26	Option Exercise	0.00	59,766	0	59,766	May 13 04:53 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '26	Option Exercise	0.00	33,167	0	113,744	Apr 03 04:11 PM
McKemey Adrian	President, Drug Dev. Solutions	Apr 01 '26	Option Exercise	0.00	10,849	0	10,849	Apr 03 04:10 PM
Corcoran Daniel	SVP and General Counsel	Apr 01 '26	Option Exercise	0.00	10,849	0	27,070	Apr 03 04:09 PM
Gallagher John E	Chief Financial Officer	Apr 01 '26	Option Exercise	0.00	50,605	0	103,174	Apr 03 04:07 PM
Aspbury Robert	PRESIDENT, PREDICTIVE TECH	Apr 01 '26	Option Exercise	0.00	33,167	0	339,581	Apr 03 04:06 PM
Anhalt Rona	Chief Human Resources Officer	Apr 01 '26	Option Exercise	0.00	9,764	0	14,945	Apr 03 04:04 PM
Feehery William F	CHIEF EXECUTIVE OFFICER	Nov 11 '25	Buy	8.30	24,096	200,000	2,360,769	Nov 12 04:44 PM

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.

President of Certara Predictive TechnologiesDr. Robert P. Aspbury Ph.D.

Senior AdvisorMr. Leif E. Pedersen

President of Drug Development SolutionsDr. Adrian K. McKemey Ph.D.

CEO & DirectorMr. Jon Resnick

President & Chief Commercial OfficerMr. Julien Perrier

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERT

Certara Inc

Upgrade your Finviz experience